CDK4 and colorectal cancer: Furthermore, EOPK significantly decreased proliferation and migration, induced G1-arrest, and inhibited the expression of phospho-ERK, phospho-AKT, β-catenin, cyclin D1 and CDK4/6 in colorectal cancer cells.